{
    "clinical_study": {
        "@rank": "148196", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate patients with primary immunodeficiency disorders to\n      identify patients with mutations of the genes for the following proteins: Jak3, STAT1,\n      STAT4, interleukin-7, interleukin-7 receptor, interleukin-12 receptor subunits, and others.\n\n      Patients will undergo screening history, physical examination, and clinical laboratory\n      evaluation at referring institutions and tissue samples, or cell lines will be sent to the\n      NIH.  We will establish cell lines if necessary, prepare DNA and RNA for molecular genetic\n      analysis and study cytokine signal transduction in patient cell lines."
        }, 
        "brief_title": "Genetic Basis of Primary Immunodeficiencies", 
        "condition": "Immunologic Deficiency Syndrome", 
        "condition_browse": {
            "mesh_term": "Immunologic Deficiency Syndromes"
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to evaluate patients with primary immunodeficiency disorders to\n      identify patients with mutations of the genes for the following proteins: Jak3, STAT1,\n      STAT4, interleukin-7, interleukin-7 receptor, interleukin-12 receptor subunits, and others.\n      Patients will undergo screening history, physical examination, and clinical laboratory\n      evaluation at referring institutions and tissue samples, or cell lines will be sent to the\n      NIH.  We will establish cell lines if necessary, prepare DNA and RNA for molecular genetic\n      analysis and study cytokine signal transduction in patient cell lines."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Samples from patients with known or suspected primary immunodeficiencies, including those\n        treated with stem cell transplants or gene correction therapy, and their families will be\n        accepted worldwide primarily from tertiary care centers that treat patients with such\n        immunodeficiencies.\n\n        Such patients will have documented evidence of either opportunistic infection, recurrent\n        infection, or unusually severe responses to infectious agents that cause mild illness in\n        unaffected individuals.\n\n        Either patient-derived B cell lines or primary blood samples will be accepted although in\n        some cases buccal swabs will also be accepted.\n\n        Samples will not be obtained from unaffected children.\n\n        Infants with SCID or other primary immunodeficiency will not be seen; their physicians\n        will care them for and only clinical material will be sent on such patients.\n\n        Medically stable patients with mild to moderate immunodeficiency may be seen at the NIH.\n\n        EXCLUSION CRITERIA:\n\n        Inability to provide informed consent.\n\n        A presence of any medical condition that would, in the opinion of the investigators,\n        confuse the interpretation of the study (e.g., HIV infection)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "99999999", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001788", 
            "org_study_id": "990004", 
            "secondary_id": "99-AR-0004"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cytokine", 
            "Stat", 
            "Jak", 
            "IL-12", 
            "Mutation", 
            "Immunodeficiency"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "link": {
            "description": "NIH Clinical Center Detailed Web Page", 
            "url": "http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1999-AR-0004.html"
        }, 
        "location": {
            "contact": {
                "email": "prpl@mail.cc.nih.gov", 
                "last_name": "For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)", 
                "phone": "800-411-1222", 
                "phone_ext": "TTY8664111010"
            }, 
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Molecular Basis of Primary Immunodeficiencies", 
        "overall_contact": {
            "email": "siegelr@mail.nih.gov", 
            "last_name": "Richard M Siegel, M.D.", 
            "phone": "(301) 496-3761"
        }, 
        "overall_contact_backup": {
            "email": "hansonep@mail.nih.gov", 
            "last_name": "Eric P Hanson, M.D.", 
            "phone": "(301) 402-6776"
        }, 
        "overall_official": {
            "affiliation": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", 
            "last_name": "Eric P Hanson, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "9143683", 
                "citation": "Fischer A, Cavazzana-Calvo M, De Saint Basile G, DeVillartay JP, Di Santo JP, Hivroz C, Rieux-Laucat F, Le Deist F. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol. 1997;15:93-124. Review."
            }, 
            {
                "PMID": "8893001", 
                "citation": "Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996 Oct 31;383(6603):787-93. Review."
            }, 
            {
                "PMID": "12021239", 
                "citation": "Candotti F, Notarangelo L, Visconti R, O'Shea J. Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways. J Clin Invest. 2002 May;109(10):1261-9. Review. No abstract available."
            }
        ], 
        "removed_countries": {
            "country": "Italy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001788"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "October 1998", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}